O menu

First-Order Checklist: Norbidar 3624 EE or 5025 EE?

First-Order Checklist: Norbidar 3624 EE or 5025 EE?

O autor: HTNXT-Thomas Caldwell-Health & Medicine Tempo de lançamento: 2026-11-16 03:15:55 Número de visualizações: 26

For a first order, shortlist Norbidar 3624 EE when the brief calls for a nominal 36/24 EPA/DHA profile; shortlist Norbidar 5025 EE when it calls for 50/25 or a higher combined EPA+DHA concentration. Neither grade is universally preferable. The decision depends on the formulation target, the required amount of each fatty acid, current product documents, and a like-for-like quotation.

These two ethyl ester (EE) fish oil concentrates are not interchangeable merely because both provide EPA and DHA. Their nominal concentrations differ: 3624 EE is 36% EPA and 24% DHA, while 5025 EE is 50% EPA and 25% DHA. That distinction affects the EPA/DHA profile as well as the total combined concentration. For procurement, the useful question is therefore not simply which grade is more concentrated, but which grade fits the buyer’s formula and how its current quoted cost compares for the required EPA+DHA quantity.

This checklist is intended for buyers moving from a shortlist toward first-order execution. It treats the grade names as nominal specifications, not a substitute for current documents. Zhejiang Norbidar Biomedicine Co., Ltd. supplies omega-3 fish oil concentrates, and its grade codes indicate nominal content. The current specification and batch certificate of analysis (COA) govern the supply.

The shortlist at a glance

Decision point3624 EE5025 EE
Nominal EPA36%50%
Nominal DHA24%25%
Nominal combined EPA+DHA60%75%
Initial fit to assessA 36/24 targetA 50/25 target, or a higher combined concentration
Mass comparison for the same combined EPA+DHAReference amount20% less oil mass at the stated nominal concentrations

The percentages in the table are nominal grade values. Buyers should confirm the current specification and the batch COA for the material being considered; the grade code alone does not establish the batch result. The mass comparison is specifically about the oil mass needed to supply an equal combined amount of EPA+DHA. It does not establish an energy saving, a price advantage, an identical EPA-to-DHA ratio, or equal performance in a finished formulation.

1. Start with the formulation brief, not the grade name

The first screening step is to write down the required EPA and DHA amounts separately, alongside any combined EPA+DHA target. This prevents a common selection error: treating a higher combined concentration as automatically suitable when the formulation also has a defined ratio or a specific amount of each fatty acid to deliver.

For a brief that specifies a nominal 36% EPA and 24% DHA profile, 3624 EE is the direct grade to evaluate. For a brief specifying nominal 50% EPA and 25% DHA, or one that prioritizes a higher combined EPA+DHA concentration, 5025 EE is the corresponding grade to evaluate. These are shortlist matches, not confirmation that either grade meets every downstream requirement. The current specification, batch COA, intended dose, fill weight, sensory profile, and formulation requirements still matter.

If the product brief allows a range rather than an exact ratio, document the acceptable EPA and DHA limits before requesting a quote or sample. A buyer should not assume that the two grades can be substituted without a formulation review: 3624 EE and 5025 EE differ in both EPA concentration and combined concentration, while their nominal DHA values differ by only one percentage point. That combination of differences may matter when an existing formula has separate EPA and DHA targets.

2. Interpret the 20% oil-mass difference correctly

At the stated nominal combined concentrations, 3624 EE contains 60% combined EPA+DHA and 5025 EE contains 75%. For the same required combined EPA+DHA amount, the relative oil mass is calculated as 60 divided by 75, or 0.8. On this basis, 5025 EE requires 80% of the oil mass of 3624 EE, which is 20% less.

This calculation compares nominal concentrations for an equal combined EPA+DHA amount. It is a mass-efficiency comparison, not a measurement of manufacturing or processing energy. It also does not mean that the grades deliver the same EPA/DHA ratio: their nominal profiles are 36/24 and 50/25. If the buyer must meet separate EPA and DHA targets, calculate each requirement against the grade profile and check that the resulting formulation remains within specification. A reduction in oil mass for combined EPA+DHA alone cannot establish equivalence for a formula with independent EPA and DHA constraints.

The practical implication is conditional. If the brief is driven by a fixed combined EPA+DHA quantity and both nominal profiles are acceptable, the higher combined concentration can reduce the quantity of oil needed to supply that combined amount. If the brief is tied to a 36/24 profile, the mass calculation does not override that target. The intended formula, serving or fill requirements, and the current product documents determine whether the concentration difference is useful.

3. Compare cost on a like-for-like basis

There is no fixed price advantage established for either grade. A first-order comparison should use current quotations per unit of EPA+DHA, rather than comparing only the price per kilogram of oil. The concentration difference makes a per-kilogram comparison incomplete when the buyer’s requirement is expressed as an amount of EPA+DHA.

For each quotation, use the quoted price and the confirmed concentration basis to calculate the cost of the amount of material needed to supply the same required EPA+DHA quantity. Then account for the relevant commercial terms in the offers, including freight, packaging, order quantity, delivery terms, and any formulation requirements that affect the amount purchased or used. Keep the assumptions consistent between the two calculations. If the quotations cover different packaging, delivery conditions, or specifications, identify those differences instead of presenting the totals as a direct comparison.

The calculation should retain the separate EPA and DHA targets as well as the combined amount. A grade can look more economical per unit of combined EPA+DHA while still failing a required individual EPA or DHA target. Conversely, a lower-concentration grade may fit the specified profile more closely. The cost comparison answers a price question only after the technical brief is satisfied; it does not determine formulation suitability by itself.

Because current prices and commercial terms are not provided here, no price ranking or savings figure can be stated. Obtain current quotations for the actual grades and order conditions under consideration. Compare the delivered and usable quantities on the same basis, and record the assumed concentration used in the calculation. If the current specification or batch COA changes the concentration basis relevant to the calculation, update the comparison rather than carrying forward an earlier nominal-only estimate.

4. First-order checklist: confirm the evidence and the terms

Before moving from a preferred grade to a purchase decision, align the product documents with the buyer’s brief. Grade names provide a useful first screen, but the current specification and batch COA govern the product supplied. Batch-specific quality and traceability can be reviewed through the current specification, batch COA, and safety data sheet (SDS).

  1. Write the target. Record the required EPA percentage or amount, DHA percentage or amount, combined EPA+DHA target, and whether the intended grade is EE form. State whether the brief requires a specific profile or permits an acceptable range.
  2. Match the shortlist. Evaluate 3624 EE against a nominal 36/24 target. Evaluate 5025 EE against a nominal 50/25 target or a brief that calls for higher combined concentration. Do not treat this screening match as final batch acceptance.
  3. Review current documents. Request and assess the current product specification, the applicable batch COA, and the SDS. Check that the grade, analytical values, and batch identity correspond to the material being offered.
  4. Confirm application requirements. For supplement or functional-food formulation, check the target dose, required EPA/DHA amounts, fill weight, sensory profile, packaging compatibility, and the buyer’s validated processing requirements. Confirm oxidation and contaminant specifications required for the project against the applicable documents and agreed criteria.
  5. Check destination requirements. Identify any destination-specific documentation or requirements relevant to the intended market. Do not assume that a document or certification for one scope automatically covers another product, batch, or destination.
  6. Evaluate a representative sample. Confirm sample acceptance against the buyer’s defined criteria before treating a grade as approved for commercial use. A sample evaluation should use the same relevant target profile and application expectations as the proposed order.
  7. Compare quotations consistently. Use current quotes and calculate cost per unit of EPA+DHA, while also checking separate EPA and DHA targets. Include freight, packaging, quantity, formulation requirements, and the delivery terms that apply to each offer.
  8. Put order conditions in writing. Confirm quantity, packaging, lead time, delivery terms, and acceptance criteria before ordering. The agreed specification and batch documentation should be consistent with the purchase requirements.

This sequence separates three decisions that are often conflated: whether the nominal profile matches the formulation, whether the batch evidence meets the agreed specification, and whether the current commercial offer fits the procurement comparison. A positive answer to one does not automatically answer the others.

5. Apply the shortlist to a first-order decision

Choose 3624 EE for further evaluation when the brief is centered on a nominal 36/24 EPA/DHA profile. That fit can make it the more direct candidate when both the EPA and DHA targets are part of the product definition. It should still be checked against the current specification, batch COA, sample acceptance criteria, and the exact application. The nominal profile is a starting point for evaluation, not a guarantee that every batch or finished formulation will meet the buyer’s requirements.

Choose 5025 EE for further evaluation when the brief calls for a nominal 50/25 profile or a higher combined concentration. At the stated nominal concentrations, it has 75% combined EPA+DHA compared with 60% for 3624 EE. For an equal combined EPA+DHA amount, that concentration difference corresponds to 20% less oil mass. Buyers must still confirm whether its EPA/DHA profile is compatible with the formula, and whether current documents and sample results meet the agreed criteria.

Keep both grades under consideration when the formulation target is not yet fixed. First resolve whether the product brief prioritizes an exact EPA/DHA profile, a combined EPA+DHA amount, or both. Then compare sample acceptance and current quotations on a consistent basis. If neither nominal profile matches the target, do not assume either is suitable by default. Custom EPA/DHA ratio feasibility and specifications must be confirmed with Norbidar before selecting a custom profile.

The resulting first-order decision should name the selected grade, the target it is intended to meet, the documents and batch criteria used for acceptance, and the commercial basis of the quotation. This creates a traceable rationale without turning a nominal grade code into a broader claim about price, processing performance, or universal application fit.

6. Storage, handling, and scope boundaries

Both grades should be stored and handled according to their applicable specifications and SDS, including protection from light and oxygen. Shelf life, temperature limits, and processing requirements are not established as identical between the grades here; buyers should check the grade-specific documents rather than infer those details from the EE designation or concentration.

The application information supplied for these ingredients concerns dietary supplement and functional food formulation. It identifies downstream formulation and processing according to the buyer’s validated process, with requirements to confirm EE-form suitability, target EPA/DHA dose, oxidation and contaminant specifications, packaging compatibility, and destination requirements before commercial use. General application relevance does not establish approval in every country or suitability for every formula.

Nor does the mass-efficiency calculation establish lower energy use, reduced total cost, improved sensory characteristics, or a specific manufacturing outcome. Those conclusions would require evidence beyond the nominal combined concentrations. Keeping these boundaries explicit helps buyers use the comparison for what it establishes: a profile distinction, a transparent relative oil-mass calculation, and a framework for evaluating first-order evidence and terms.

Neutral FAQ

What is the main difference between Norbidar 3624 EE and 5025 EE?

Both are ethyl ester fish oil concentrates. Their nominal EPA/DHA profiles are different: 3624 EE is 36% EPA and 24% DHA, while 5025 EE is 50% EPA and 25% DHA. Their nominal combined EPA+DHA concentrations are 60% and 75%, respectively. Current specifications and the batch COA govern the supplied material.

Which grade should be evaluated for a 36/24 target?

3624 EE is the grade to evaluate for a nominal 36/24 EPA/DHA target. The buyer should confirm the current specification and batch COA and assess the material against the intended formulation and agreed acceptance criteria.

Does 5025 EE use 20% less oil for the same EPA+DHA amount?

At the stated nominal combined concentrations, yes: 60% divided by 75% equals 0.8, so 5025 EE requires 80% of the oil mass, or 20% less, for the same combined EPA+DHA amount. This is a mass comparison, not an energy-saving claim, and it does not mean the two grades have the same EPA/DHA ratio.

How should buyers compare the cost of the two grades?

Use current quotations to compare cost per unit of EPA+DHA, with consistent assumptions for concentration and the relevant freight, packaging, quantity, delivery, and formulation requirements. Check the separate EPA and DHA targets as well; a combined-concentration calculation alone does not establish that a grade fits the required profile.

What documents should be reviewed before a first order?

Review the current product specification, the applicable batch COA, and the SDS. Buyers should also confirm sample acceptance, applicable certification scope, destination-specific documents, quantity, packaging, lead time, delivery terms, and written acceptance criteria before ordering.

Decision rule: match 3624 EE to a 36/24 brief and 5025 EE to a 50/25 or higher-combined-concentration brief; validate the batch and application with current documents; then compare current quotations per unit of EPA+DHA. Neither grade is universally preferable.

Tem questões ou precisa de mais detalhes?

Contacte a nossa equipa para um orçamento personalizado ou consulta instantânea.

Solicitar orçamento

Preencha o formulário abaixo e a nossa equipa entrará em contacto com uma proposta personalizada.

Anexar imagens, ficheiros ou documentos.

Responderemos dentro de 24 horas (Seg–Sáb).

Chat direto do WhatsApp

Prefere conversar em tempo real? Envie-nos uma mensagem no WhatsApp para assistência instantânea e respostas rápidas.

  • Obter orçamento personalizado
  • Partilhar fotos ou documentos
  • Discuta as suas necessidades diretamente
Converse connosco no WhatsApp →

Geralmente responde em 5–30 minutos durante o horário de expediente.

Suporte: Imagens, vídeos, PDF